Methamphetamine-induced spectrin proteolysis in the rat striatum

Journal of Neurochemistry

Volumn 96, Issue 5, 2006, Pages 1267-1276

  Staszewski, Robert D ^a   Yamamoto, Bryan K ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calpain; Excitotoxicity; Glutamate; Methamphetamine; Spectrin

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; DOPAMINE; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SEROTONIN; SPECTRIN; TRYPTOPHAN HYDROXYLASE; TYROSINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; DRUG EFFECT; DRUG MEGADOSE; HYPERTHERMIA; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; TEMPERATURE MEASUREMENT;

ANIMALS; BENZODIAZEPINES; BLOTTING, WESTERN; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; MALE; METHAMPHETAMINE; MOLECULAR WEIGHT; RATS; RATS, SPRAGUE-DAWLEY; SPECTRIN; TIME FACTORS;

ANIMALIA;

EID: 33645106887     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03618.x     Document Type: Article

References (65)

1. Abekawa T. Ohmori T. Koyama T. 1994 Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens Brain Res 643 276 281
2. Abellan MT. Martin-Ruiz R. Artigas F. 2000 Local modulation of the 5-HT release in the dorsal striatum of the rat: an in vivo microdialysis study EurNeuropsychopharmacol 10 455 462
3. Albers DS. Sonsalla PK. 1995 Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents JPharmacolExpTher 275 1104 1114
4. Ali SF. Newport GD. Holson RR. Slikker W. Jr. Bowyer JF. 1994 Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice Brain Res 658 33 38
5. Arvin B. Lekieffre D. Graham JL. Moncada C. Chapman AG. Meldrum BS. 1994 Effect of the non-NMDA receptor antagonist GYKI 52466 on the microdialysate and tissue concentrations of amino acids following transient forebrain ischaemia JNeurochem 62 1458 1467
6. Bakhit C. Morgan ME. Peat MA. Gibb JW. 1981 Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain Neuropharmacology 20 1135 1140
7. Bartus RT. Dean RL. Mennerick S. Eveleth D. Lynch G. 1998 Temporal ordering of pathogenic events following transient global ischemia Brain Res 790 1 13
8. Battaglia G. Fornai F. Busceti CL. Aloisi G. Cerrito F. De Blasi A. Melchiorri D. Nicoletti F. 2002 Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity JNeurosci 22 2135 2141
9. Beer R. Franz G. Srinivasan A. et al. 2000 Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury JNeurochem 75 1264 1273
10. Betarbet R. Greenamyre JT. 1999 Differential expression of glutamate receptors by the dopaminergic neurons of the primate striatum ExpNeurol 159 401 408
11. Block F. Schmitt W. Schwarz M. 1996 Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats JNeurolSci 139 167 172
12. Bowyer JF. Davies DL. Schmued L. Broening HW. Newport GD. Slikker W. Jr. Holson RR. 1994 Further studies of the role of hyperthermia in methamphetamine neurotoxicity JPharmacolExpTher 268 1571 1580
13. Buki A. Koizumi H. Povlishock JT. 1999 Moderate posttraumatic hypothermia decreases early calpain-mediated proteolysis and concomitant cytoskeletal compromise in traumatic axonal injury ExpNeurol 159 319 328
14. Burrows KB. Yamamoto BK. 2003 Methamphetamine toxicity: roles for glutamate, oxidative processes and metabolic stress, in Contemporary Clinical Neuroscience: Glutamate and Addiction Herman BH., ed.), pp. 211 226 Humana
15. Chapman DE. Hanson GR. Kesner RP. Keefe KA. 2001 Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine JPharmacolExpTher 296 520 527
16. Dunah AW. Wang Y. Yasuda RP. Kameyama K. Huganir RL. Wolfe BB. Standaert DG. 2000 Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl- d -aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease MolPharmacol 57 342 352
17. Fan XD. Li XM. Ashe PC. Juorio AV. 1999 Lesion of the substantia nigra pars compacta downregulates striatal glutamate receptor subunit mRNA expression Brain Res 850 79 86
18. Fleckenstein AE. Metzger RR. Beyeler ML. Gibb JW. Hanson GR. 1997a Oxygen radicals diminish dopamine transporter function in rat striatum EurJPharmacol 334 111 114
19. Fleckenstein AE. Wilkins DG. Gibb JW. Hanson GR. 1997b Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration JPharmacolExpTher 283 281 285
20. Gibb JW. Kogan FJ. 1979 Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity Naunyn Schmiedebergs ArchPharmacol 310 185 187
21. Golembiowska K. Konieczny J. Wolfarth S. Ossowska K. 2003 Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats Neuropharmacology 45 484 492
22. Green AR. De Souza RJ. Williams JL. Murray TK. Cross AJ. 1992 The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole Neuropharmacology 31 315 321
23. Harold C. Wallace T. Friedman R. Gudelsky G. Yamamoto B. 2000 Methamphetamine selectively alters brain glutathione EurJPharmacol 400 99 102
24. Harris AS. Morrow JS. 1988 Proteolytic processing of human brain alpha spectrin (fodrin): identification of a hypersensitive site JNeurosci 8 2640 2651
25. Hernandez LF. Segovia G. Mora F. 2003 Effects of activation of NMDA and AMPA glutamate receptors on the extracellular concentrations of dopamine, acetylcholine, and GABA in striatum of the awake rat: a microdialysis study NeurochemRes 28 1819 1827
26. Hollmann M. Hartley M. Heinemann S. 1991 Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition Science 252 851 853
27. Hotchkiss AJ. Morgan ME. Gibb JW. 1979 The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities Life Sci 25 1373 1378
28. Itzhak Y. Martin JL. Ail SF. 2000 nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice Neuroreport 11 2943 2946
29. Jayanthi S. Deng X. Noailles PA. Ladenheim B. Cadet JL. 2004 Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades FASEB J 18 238 251
30. Keefe KA. Zigmond MJ. Abercrombie ED. 1993 In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids JNeural TransmGenSect 91 223 240
31. Kitagawa K. Matsumoto M. Saido TC. Ohtsuki T. Kuwabara K. Yagita Y. Mabuchi T. Yanagihara T. Hori M. 1999 Species differences in fodrin proteolysis in the ischemic brain JNeurosciRes 55 643 649
32. Lai SK. Tse YC. Yang MS. Wong CK. Chan YS. Yung KK. 2003 Gene expression of glutamate receptors GluR1 and NR1 is differentially modulated in striatal neurons in rats after 6-hydroxydopamine lesion NeurochemInt 43 639 653
33. LaVoie MJ. Hastings TG. 1999 Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine JNeurosci 19 1484 1491
34. Le Peillet E. Arvin B. Moncada C. Meldrum BS. 1992 The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat Brain Res 571 115 120
35. Lee KS. Frank S. Vanderklish P. Arai A. Lynch G. 1991 Inhibition of proteolysis protects hippocampal neurons from ischemia ProcNatl AcadSciUSA 88 7233 7237
36. Lu T. Xu Y. Mericle MT. Mellgren RL. 2002 Participation of the conventional calpains in apoptosis BiochimBiophysActa 1590 16 26
37. McGinnis KM. Whitton MM. Gnegy ME. Wang KK. 1998 Calcium/calmodulin- dependent protein kinase IV is cleaved by caspase-3 and calpain in SH-SY5Y human neuroblastoma cells undergoing apoptosis JBiolChem 273 19 993 20 000
38. Minger SL. Geddes JW. Holtz ML. Craddock SD. Whiteheart SW. Siman RG. Pettigrew LC. 1998 Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia Brain Res 810 181 199
39. Morimoto T. Ginsberg MD. Dietrich WD. Zhao W. 1997 Hyperthermia enhances spectrin breakdown in transient focal cerebral ischemia Brain Res 746 43 51
40. Nash JF. Yamamoto BK. 1992 Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine Brain Res 581 237 243
41. O'Dell SJ. Weihmuller FB. Marshall JF. 1991 Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity Brain Res 564 256 260
42. Ohta K. Araki N. Shibata M. Komatsumoto S. Shimazu K. Fukuuchi Y. 1994 Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine: involvement of both NMDA and AMPA/kainate subtypes NeurosciRes 21 83 89
43. Pike BR. Zhao X. Newcomb JK. Wang KK. Posmantur RM. Hayes RL. 1998 Temporal relationships between de novo protein synthesis, calpain and caspase 3-like protease activation, and DNA fragmentation during apoptosis in septo-hippocampal cultures JNeurosciRes 52 505 520
44. Pike BR. Flint J. Dutta S. Johnson E. Wang KK. Hayes RL. 2001 Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats JNeurochem 78 1297 1306
45. Pike BR. Flint J. Dave JR. Lu XC. Wang KK. Tortella FC. Hayes RL. 2004 Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats JCerebBlood Flow Metab 24 98 106
46. Ricaurte GA. Guillery RW. Seiden LS. Schuster CR. Moore RY. 1982 Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain Brain Res 235 93 103
47. Sakai K. Akiyama K. Kashihara K. Tsuchida K. Ujike H. Kuroda S. Shohmori T. 1997 AMPA receptors modulate dopamine release in the striatum, as measured by brain microdialysis NeurochemInt 30 329 336
48. Schmidt CJ. Gibb JW. 1985 Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine NeurochemRes 10 637 648
49. Segovia G. Del Arco A. Mora F. 1997 Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a microdialysis study JNeurochem 69 1476 1483
50. Seiden LS. Commins DL. Vosmer G. Axt K. Marek G. 1988 Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections AnnN Y AcadSci 537 161 172
51. Seubert P. Ivy G. Larson J. Lee J. Shahi K. Baudry M. Lynch G. 1988a Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. I. Biochemical studies Brain Res 459 226 232
52. Seubert P. Larson J. Oliver M. Jung MW. Baudry M. Lynch G. 1988b Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampus Brain Res 460 189 194
53. Siman R. Noszek JC. 1988 Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo Neuron 1 279 287
54. Siman R. Noszek JC. Kegerise C. 1989 Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage JNeurosci 9 1579 1590
55. Sonsalla PK. Riordan DE. Heikkila RE. 1991 Competitive and noncompetitive antagonists at N-methyl- d -aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice JPharmacolExpTher 256 506 512
56. Stephans SE. Yamamoto BK. 1994 Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux Synapse 17 203 209
57. Stephans S. Yamamoto B. 1996 Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity Neuroscience 72 593 600
58. Wagner GC. Carelli RM. Jarvis MF. 1985 Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats ResCommunChemPatholPharmacol 47 221 228
59. Wagner GC. Ricaurte GA. Seiden LS. Schuster CR. Miller RJ. Westley J. 1980 Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine Brain Res 181 151 160
60. Wallace TL. Vorhees CV. Zemlan FP. Gudelsky GA. 2003 Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain Neuroscience 116 1063 1068
61. Wang KK. 2000 Calpain and caspase: can you tell the difference? Trends Neurosci 23 20 26
62. Wang KK. Posmantur R. Nath R. McGinnis K. Whitton M. Talanian RV. Glantz SB. Morrow JS. 1998 Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells JBiolChem 273 22 490 22 497
63. Yamamoto BK. Zhu W. 1998 The effects of methamphetamine on the production of free radicals and oxidative stress JPharmacolExpTher 287 107 114
64. Zhang C. Siman R. Xu YA. Mills AM. Frederick JR. Neumar RW. 2002 Comparison of calpain and caspase activities in the adult rat brain after transient forebrain ischemia NeurobiolDis 10 289 205
65. Zhao X. Pike BR. Newcomb JK. Wang KK. Posmantur RM. Hayes RL. 1999 Maitotoxin induces calpain but not caspase-3 activation and necrotic cell death in primary septo-hippocampal cultures NeurochemRes 24 371 382